- Heat Biologics (HTBX): Q2 GAAP EPS of -$0.14 in-line.
- Grant and licensing revenue of $0.34M (-70.2% Y/Y) misses by $0.53M.
- Cash, cash equivalents and short-term investments of $19.5M
- Press Release
Heat Biologics EPS in-line, misses on revenue
Recommended For You
More Trending News
About SCPX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SCPX | - | - |
| Scorpius Holdings, Inc. | ||